Bioavailability Study of Ondansetron 24 mg Orally Disintegrating Tablets Under Fasting Conditions
- First Posted Date
- 2008-04-16
- Last Posted Date
- 2008-04-16
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT00659074
- Locations
- 🇨🇦
Algorithme Pharma, Laval, Quebec, Canada
Bioavailability Study of Ondansetron 16 mg Orally Disintegrating Tablets Under Fasting Conditions
- First Posted Date
- 2008-04-16
- Last Posted Date
- 2008-04-16
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT00659685
- Locations
- 🇨🇦
Algorithme Pharma, Laval, Quebec, Canada
Bioavailability Study of Torsemide Tablets Under Fasting Conditions
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-04-07
- Last Posted Date
- 2011-06-17
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT00653549
Bioavailability Study of Ondansetron Orally Disintegrating Tablets Under Fed Conditions
- First Posted Date
- 2008-04-07
- Last Posted Date
- 2008-04-11
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT00653458
Bioavailability Study of Torsemide Tablets Under Fed Conditions
- First Posted Date
- 2008-04-07
- Last Posted Date
- 2008-04-11
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT00654043
Bioavailability Study of Ondansetron Orally Disintegrating Tablets Under Fasting Conditions
- First Posted Date
- 2008-04-07
- Last Posted Date
- 2008-04-11
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT00654277
Bioavailability Study of Oxandrolone Tablets Under Fasting Conditions
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-04-04
- Last Posted Date
- 2008-04-04
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT00652886
- Locations
- 🇺🇸
Gateway Medical Research, Inc, St.Charles, Missouri, United States
Bioavailability Study of Propranolol Under Fed Conditions
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-04-04
- Last Posted Date
- 2017-09-26
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 46
- Registration Number
- NCT00652600
Bioavailability Study of Clonazepam ODT Under Fasting Conditions
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-04-04
- Last Posted Date
- 2008-04-04
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT00652912
Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting and Fed Conditions
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-04-04
- Last Posted Date
- 2017-09-26
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 21
- Registration Number
- NCT00652730
- Locations
- 🇨🇦
Phoenix International Life Sciences inc, St-Laurent, Quebec, Canada
© Copyright 2024. All Rights Reserved by MedPath